Adrecizumab
Showing 1 - 6 of 6
COVID-19 Trial (Adrecizumab (HAM 8101), Placebo)
Not yet recruiting
- COVID-19
- Adrecizumab (HAM 8101)
- Placebo
- (no location specified)
Jun 29, 2022
Cardiogenic Shock, Endothelial Dysfunction Trial in Berlin, Hamburg, Ulm (Adrecizumab, Placebo)
Completed
- Cardiogenic Shock
- Endothelial Dysfunction
- Adrecizumab
- Placebo
-
Berlin, Germany
- +2 more
Oct 7, 2021
Acute Heart Failure Trial in Malang, Yogyakarta (Adrecizumab)
Recruiting
- Acute Heart Failure
- Adrecizumab
-
Malang, Indonesia
- +1 more
Mar 8, 2021
Healthy Volunteers Trial in Nijmegen (Endotoxin, Placebo, Adrecizumab)
Completed
- Healthy Volunteers
- Endotoxin
- +2 more
-
Nijmegen, Gelderland, NetherlandsDept. of Intensive Care Medicine, Research-unit, Radboud univers
Jan 29, 2021
Healthy Volunteers Trial in Nijmegen (Placebo, Adrecizumab)
Completed
- Healthy Volunteers
- Placebo
- Adrecizumab
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Mar 13, 2017